Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.

Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL.

Cancer. 2014 Jul 1;120(13):2000-5. doi: 10.1002/cncr.28690.

2.

Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.

Molica S, Giannarelli D, Mirabelli R, Levato L, Gentile M, Lentini M, Morabito F.

Expert Rev Hematol. 2014 Oct;7(5):691-5. doi: 10.1586/17474086.2014.954542.

PMID:
25174547
3.

The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.

Dagklis A, Fazi C, Sala C, Cantarelli V, Scielzo C, Massacane R, Toniolo D, Caligaris-Cappio F, Stamatopoulos K, Ghia P.

Blood. 2009 Jul 2;114(1):26-32. doi: 10.1182/blood-2008-09-176933.

4.

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.

Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA.

J Clin Oncol. 2009 Aug 20;27(24):3959-63. doi: 10.1200/JCO.2008.21.2704.

5.

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA.

Blood. 2009 Apr 30;113(18):4188-96. doi: 10.1182/blood-2008-09-176149.

6.
7.

Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.

Healey R, Patel JL, de Koning L, Naugler C.

Leuk Res. 2015 Apr;39(4):429-34. doi: 10.1016/j.leukres.2015.01.015.

PMID:
25703352
8.

Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.

Molica S, Mauro FR, Molica M, Del Giudice I, Foà R.

Leuk Lymphoma. 2012 Sep;53(9):1660-5. doi: 10.3109/10428194.2012.666542. Review.

PMID:
22335530
9.

Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.

Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, Liso V, Cuneo A, Foà R.

Haematologica. 2011 Feb;96(2):277-83. doi: 10.3324/haematol.2010.030189.

10.

Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.

Nieto WG, Teodosio C, López A, Rodríguez-Caballero A, Romero A, Bárcena P, Gutierrez ML, Langerak AW, Fernandez-Navarro P, Orfao A, Almeida J; Primary Health Care Group of Salamanca for the Study of MBL..

Cytometry B Clin Cytom. 2010;78 Suppl 1:S24-34. doi: 10.1002/cyto.b.20543.

11.

[Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].

Schindhelm RK, van Marwijk Kooy MR, Coenen JL, Huijgens PC, Kuiper-Kramer PA.

Ned Tijdschr Geneeskd. 2010;154:A1520. Review. Dutch.

PMID:
20482911
12.

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA.

Leuk Res. 2008 Sep;32(9):1458-61. doi: 10.1016/j.leukres.2007.11.030.

13.

[Monoclonal B-cell lymphocytosis: from literature to laboratory practice].

Keutgens A, Foguenne J, Gothot A, Tassin F.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):168-75. doi: 10.1684/abc.2016.1127. Review. French.

PMID:
27029722
14.

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Strati P, Shanafelt TD.

Blood. 2015 Jul 23;126(4):454-62. doi: 10.1182/blood-2015-02-585059. Review.

15.

What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.

Scarfò L, Ghia P.

Semin Oncol. 2016 Apr;43(2):201-8. doi: 10.1053/j.seminoncol.2016.02.013. Review.

PMID:
27040697
16.

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.

Fung SS, Hillier KL, Leger CS, Sandhu I, Vickars LM, Galbraith PF, Li CH, Leitch HA.

Leuk Lymphoma. 2007 Jun;48(6):1087-91.

PMID:
17577771
17.

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).

Molica S, Giannarelli D, Levato L, Mirabelli R, Gentile M, Lentini M, Morabito F.

Int J Hematol. 2014 Sep;100(3):290-5. doi: 10.1007/s12185-014-1634-7.

PMID:
25064370
18.

Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Algood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE.

Br J Haematol. 2010 Oct;151(2):152-8. doi: 10.1111/j.1365-2141.2010.08339.x.

19.

Monoclonal B-cell lymphocytosis.

Rawstron AC.

Hematology Am Soc Hematol Educ Program. 2009:430-9. doi: 10.1182/asheducation-2009.1.430. Review. Erratum in: Hematology Am Soc Hematol Educ Program. 2011;2011:561.

PMID:
20008229
20.

Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL).

Mulligan CS, Thomas ME, Mulligan SP.

Blood. 2009 Jun 18;113(25):6496-7; author reply 6497-8. doi: 10.1182/blood-2008-07-166710. No abstract available.

Items per page

Supplemental Content

Support Center